Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taro Takami

Showing results (131-140 of 175) with videos related to

Pageof 18
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2013
Serum transferrin as a predictor of prognosis for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinomaJunichi Zaitsu, Takahiro Yamasaki, Issei Saeki, et al.
Liver Cancer|August 18, 2022
Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia AssessmentTakahiro Yamasaki, Issei Saeki, Yurika Yamauchi, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|June 2, 2024
Far-ultraviolet irradiation at 222 nm destroys and sterilizes the biofilms formed by periodontitis pathogensJun Nishikawa, Tomohiro Fujii, Soichiro Fukuda, et al.
International Journal of Molecular Sciences|September 23, 2022
MC180295 Inhibited Epstein-Barr Virus-Associated Gastric Carcinoma Cell Growth by Suppressing DNA Repair and the Cell CycleTomohiro Fujii, Jun Nishikawa, Soichiro Fukuda, et al.
Cancers|April 1, 2020
Blood Free-Circulating DNA Testing of Methylated RUNX3 Is Useful for Diagnosing Early Gastric CancerEizaburou Hideura, Yutaka Suehiro, Jun Nishikawa, et al.
Pancreas|March 26, 2024
Multicenter Prospective Cohort Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer (YPB-001)Hiroto Matsui, Tatsuya Ioka, Tsuyoshi Takahashi, et al.
Oncology|September 5, 2024
A Novel Index Including Age, Sex, hTERT, and Methylated RUNX3 Is Useful for Diagnosing Early Gastric CancerKatsuhiko Nakamura, Yutaka Suehiro, Koichi Hamabe, et al.
Hepatology Communications|March 7, 2020
Novel Liquid Biopsy Test Based on a Sensitive Methylated <i>SEPT9</i> Assay for Diagnosing Hepatocellular CarcinomaYurika Kotoh, Yutaka Suehiro, Issei Saeki, et al.
Inflammatory Bowel Diseases|August 20, 2023
Predictive Factors for Efficacy of Oral Tacrolimus Induction Therapy in Moderate to Severe Ulcerative Colitis Patients: Large Multicenter Retrospective Cohort StudyNaoki Oshima, Sakiko Hiraoka, Ryohei Hayashi, et al.
Hepatology International|May 15, 2023
Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinomaIssei Saeki, Yutaka Suehiro, Yurika Yamauchi, et al.
Pageof 18

Showing results (131-140 of 175) with videos related to

Sort By:
Pageof 18
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 24, 2013
Serum transferrin as a predictor of prognosis for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinomaJunichi Zaitsu, Takahiro Yamasaki, Issei Saeki, et al.
Liver Cancer|August 18, 2022
Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia AssessmentTakahiro Yamasaki, Issei Saeki, Yurika Yamauchi, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|June 2, 2024
Far-ultraviolet irradiation at 222 nm destroys and sterilizes the biofilms formed by periodontitis pathogensJun Nishikawa, Tomohiro Fujii, Soichiro Fukuda, et al.
International Journal of Molecular Sciences|September 23, 2022
MC180295 Inhibited Epstein-Barr Virus-Associated Gastric Carcinoma Cell Growth by Suppressing DNA Repair and the Cell CycleTomohiro Fujii, Jun Nishikawa, Soichiro Fukuda, et al.
Cancers|April 1, 2020
Blood Free-Circulating DNA Testing of Methylated RUNX3 Is Useful for Diagnosing Early Gastric CancerEizaburou Hideura, Yutaka Suehiro, Jun Nishikawa, et al.
Pancreas|March 26, 2024
Multicenter Prospective Cohort Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer (YPB-001)Hiroto Matsui, Tatsuya Ioka, Tsuyoshi Takahashi, et al.
Oncology|September 5, 2024
A Novel Index Including Age, Sex, hTERT, and Methylated RUNX3 Is Useful for Diagnosing Early Gastric CancerKatsuhiko Nakamura, Yutaka Suehiro, Koichi Hamabe, et al.
Hepatology Communications|March 7, 2020
Novel Liquid Biopsy Test Based on a Sensitive Methylated <i>SEPT9</i> Assay for Diagnosing Hepatocellular CarcinomaYurika Kotoh, Yutaka Suehiro, Issei Saeki, et al.
Inflammatory Bowel Diseases|August 20, 2023
Predictive Factors for Efficacy of Oral Tacrolimus Induction Therapy in Moderate to Severe Ulcerative Colitis Patients: Large Multicenter Retrospective Cohort StudyNaoki Oshima, Sakiko Hiraoka, Ryohei Hayashi, et al.
Hepatology International|May 15, 2023
Methylated SEPT9 assay-based liquid biopsy as a biomarker in molecular targeted agent-treated hepatocellular carcinomaIssei Saeki, Yutaka Suehiro, Yurika Yamauchi, et al.
Pageof 18